FocalTherics

FOCL Healthcare Medical Distribution

FocalTherics' revenue for fiscal 2025 (year ended December 2025) was $70.5 million, up 1.63% from fiscal 2024. In the quarter to June 2026, revenue grew 38.9%, EPS fell 129.4%, free cash flow grew 21.5% and total debt rose 366.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

4.15 0.02 +0.48%
Market cap
$154.8M
P/E
0.0×
Fwd P/E
−4.8×
Dividend yield
—
F-score
3/9
Altman Z
−0.87
Beneish M
−3.14
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Total current assets
59.02 50.36 57.16 52.04
Total non-current assets
15.53 21.70 21.83 20.08
Total Assets
74.55 72.06 79.00 72.12
Total current liabilities
36.85 37.51 37.14 36.85
Total non-current liabilities
40.93 24.45 22.44 7.91
Total liabilities
77.77 61.96 59.58 44.76
Common Equity (Total)
(3.22) 10.10 19.41 —
Shareholders Equity (Total)
(3.22) 10.10 19.41 27.37
Total Debt
40.10 24.74 22.48 7.11

Show all line items

In millions of $ except per-share values · columns are period end dates